
Christopher Y. Kim
Examiner (ID: 18274)
| Most Active Art Unit | 1801 |
| Art Unit(s) | 1744, 2876, 1801, 1312 |
| Total Applications | 419 |
| Issued Applications | 342 |
| Pending Applications | 16 |
| Abandoned Applications | 61 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20459440
[patent_doc_number] => 20260008863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-01-08
[patent_title] => PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 19/328055
[patent_app_country] => US
[patent_app_date] => 2025-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24543
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19328055
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/328055 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | Sep 11, 2025 | Issued |
Array
(
[id] => 20459440
[patent_doc_number] => 20260008863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-01-08
[patent_title] => PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 19/328055
[patent_app_country] => US
[patent_app_date] => 2025-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24543
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19328055
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/328055 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | Sep 11, 2025 | Issued |
Array
(
[id] => 20241203
[patent_doc_number] => 12421512
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-23
[patent_title] => CRISPR/Cas screening platform to identify genetic modifiers of tau seeding or aggregation
[patent_app_type] => utility
[patent_app_number] => 18/984162
[patent_app_country] => US
[patent_app_date] => 2024-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 30
[patent_no_of_words] => 64158
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 582
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18984162
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/984162 | CRISPR/Cas screening platform to identify genetic modifiers of tau seeding or aggregation | Dec 16, 2024 | Issued |
Array
(
[id] => 20453258
[patent_doc_number] => 12516310
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Composition comprising collagenase, calcium, histidine, and glycine, and method for stabilizing collagenase
[patent_app_type] => utility
[patent_app_number] => 18/948388
[patent_app_country] => US
[patent_app_date] => 2024-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5783
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18948388
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/948388 | Composition comprising collagenase, calcium, histidine, and glycine, and method for stabilizing collagenase | Nov 13, 2024 | Issued |
Array
(
[id] => 19651311
[patent_doc_number] => 12173080
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-12-24
[patent_title] => Prevention of disulfide bond reduction during recombinant production of polypeptides
[patent_app_type] => utility
[patent_app_number] => 18/824681
[patent_app_country] => US
[patent_app_date] => 2024-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 41
[patent_no_of_words] => 29219
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18824681
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/824681 | Prevention of disulfide bond reduction during recombinant production of polypeptides | Sep 3, 2024 | Issued |
Array
(
[id] => 19432582
[patent_doc_number] => 20240301080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 18/648209
[patent_app_country] => US
[patent_app_date] => 2024-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29376
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18648209
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/648209 | Prevention of disulfide bond reduction during recombinant production of polypeptides | Apr 25, 2024 | Issued |
Array
(
[id] => 19563548
[patent_doc_number] => 12138299
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-12
[patent_title] => Aldehyde dehydrogenase producing bacteria and methods of using same
[patent_app_type] => utility
[patent_app_number] => 18/625448
[patent_app_country] => US
[patent_app_date] => 2024-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 27
[patent_no_of_words] => 17272
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 224
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18625448
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/625448 | Aldehyde dehydrogenase producing bacteria and methods of using same | Apr 2, 2024 | Issued |
Array
(
[id] => 20272259
[patent_doc_number] => 12442030
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-14
[patent_title] => Methods and systems for determining ADAMTS13 enzyme activity
[patent_app_type] => utility
[patent_app_number] => 18/598286
[patent_app_country] => US
[patent_app_date] => 2024-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8103
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18598286
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/598286 | Methods and systems for determining ADAMTS13 enzyme activity | Mar 6, 2024 | Issued |
Array
(
[id] => 20272259
[patent_doc_number] => 12442030
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-14
[patent_title] => Methods and systems for determining ADAMTS13 enzyme activity
[patent_app_type] => utility
[patent_app_number] => 18/598286
[patent_app_country] => US
[patent_app_date] => 2024-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8103
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18598286
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/598286 | Methods and systems for determining ADAMTS13 enzyme activity | Mar 6, 2024 | Issued |
Array
(
[id] => 19381194
[patent_doc_number] => 20240271064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => ALPHA-AMYLASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME
[patent_app_type] => utility
[patent_app_number] => 18/595600
[patent_app_country] => US
[patent_app_date] => 2024-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84004
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18595600
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/595600 | Alpha-amylase variants and polynucleotides encoding same | Mar 4, 2024 | Issued |
Array
(
[id] => 19381194
[patent_doc_number] => 20240271064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => ALPHA-AMYLASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME
[patent_app_type] => utility
[patent_app_number] => 18/595600
[patent_app_country] => US
[patent_app_date] => 2024-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84004
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18595600
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/595600 | Alpha-amylase variants and polynucleotides encoding same | Mar 4, 2024 | Issued |
Array
(
[id] => 19923199
[patent_doc_number] => 12297470
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-13
[patent_title] => Polypeptides having peptidoglycan degrading activity and polynucleotides encoding same
[patent_app_type] => utility
[patent_app_number] => 18/586709
[patent_app_country] => US
[patent_app_date] => 2024-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49326
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18586709
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/586709 | Polypeptides having peptidoglycan degrading activity and polynucleotides encoding same | Feb 25, 2024 | Issued |
Array
(
[id] => 19345213
[patent_doc_number] => 20240254176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => MOLECULES FOR ORGANELLE-SPECIFIC PROTEIN DELIVERY
[patent_app_type] => utility
[patent_app_number] => 18/432505
[patent_app_country] => US
[patent_app_date] => 2024-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37702
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18432505
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/432505 | Molecules for organelle-specific protein delivery | Feb 4, 2024 | Issued |
Array
(
[id] => 19615404
[patent_doc_number] => 20240401084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/431662
[patent_app_country] => US
[patent_app_date] => 2024-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39516
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18431662
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/431662 | RNA-guided nucleases and active fragments and variants thereof and methods of use | Feb 1, 2024 | Issued |
Array
(
[id] => 19601394
[patent_doc_number] => 20240392274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => ACTIVE LOW MOLECULAR WEIGHT VARIANTS OF ANGIOTENSIN CONVERTING ENZYME 2 (ACE2)
[patent_app_type] => utility
[patent_app_number] => 18/431554
[patent_app_country] => US
[patent_app_date] => 2024-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23400
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18431554
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/431554 | ACTIVE LOW MOLECULAR WEIGHT VARIANTS OF ANGIOTENSIN CONVERTING ENZYME 2 (ACE2) | Feb 1, 2024 | Abandoned |
Array
(
[id] => 19916351
[patent_doc_number] => 12291707
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-06
[patent_title] => Modified immune cells having enhanced function and methods for screening the same
[patent_app_type] => utility
[patent_app_number] => 18/424952
[patent_app_country] => US
[patent_app_date] => 2024-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 63
[patent_no_of_words] => 54725
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18424952
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/424952 | Modified immune cells having enhanced function and methods for screening the same | Jan 28, 2024 | Issued |
Array
(
[id] => 19479433
[patent_doc_number] => 20240327475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => ICAM-1 TARGETED FUSION ENZYMES
[patent_app_type] => utility
[patent_app_number] => 18/416843
[patent_app_country] => US
[patent_app_date] => 2024-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11865
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18416843
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/416843 | ICAM-1 targeted fusion enzymes | Jan 17, 2024 | Issued |
Array
(
[id] => 19181055
[patent_doc_number] => 11987637
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-05-21
[patent_title] => Prevention of disulfide bond reduction during recombinant production of polypeptides
[patent_app_type] => utility
[patent_app_number] => 18/410876
[patent_app_country] => US
[patent_app_date] => 2024-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 41
[patent_no_of_words] => 29494
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18410876
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/410876 | Prevention of disulfide bond reduction during recombinant production of polypeptides | Jan 10, 2024 | Issued |
Array
(
[id] => 19181056
[patent_doc_number] => 11987638
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-05-21
[patent_title] => Prevention of disulfide bond reduction during recombinant production of polypeptides
[patent_app_type] => utility
[patent_app_number] => 18/410949
[patent_app_country] => US
[patent_app_date] => 2024-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 41
[patent_no_of_words] => 29107
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18410949
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/410949 | Prevention of disulfide bond reduction during recombinant production of polypeptides | Jan 10, 2024 | Issued |
Array
(
[id] => 19281864
[patent_doc_number] => 20240218338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => TREATMENT OF ABNORMAL BONE CONDITIONS IN ACID SPHINGOMYELINASE DEFICIENCY PATIENTS
[patent_app_type] => utility
[patent_app_number] => 18/409535
[patent_app_country] => US
[patent_app_date] => 2024-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10168
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18409535
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/409535 | TREATMENT OF ABNORMAL BONE CONDITIONS IN ACID SPHINGOMYELINASE DEFICIENCY PATIENTS | Jan 9, 2024 | Abandoned |